Thus, we have investigated the expression of CXC-chemokine receptors on primary RCC cultures and on kidney cancer compared to normal kidney tissue, detecting an alteration of the CXCL12/CXCR4 signalling pathway in kidney cancer. The gene discussed is CXCL12; the disease is renal cell adenocarcinoma.